Results 1 to 10 of about 380,856 (149)

The hidden threat: understanding anti-PF4 disorders without proximate heparin exposure [PDF]

open access: yesFrontiers in Immunology
Heparin-induced thrombocytopenia (HIT) is now recognized as one subset of a broader group of disorders: anti-platelet factor 4 (anti-PF4) disorders.
Zhiyan Liu   +4 more
doaj   +2 more sources

Electrospun Heparin-Loaded PCL Nanofiber Sutures with Sustained Release for Antithrombotic Applications [PDF]

open access: yesPharmaceuticals
Background/Objectives: Conventional surgical sutures can promote local coagulation after implantation, potentially compromising vascular patency. Heparin is an effective anticoagulant, but systemic administration may cause bleeding and thrombocytopenia ...
Yixiang Pan   +7 more
doaj   +2 more sources

Heparin Can Augment Extracellular Vesicle Yield by Inhibiting Reuptake in Donor Cells During Cell Propagation [PDF]

open access: yesJournal of Extracellular Vesicles
Extracellular vesicles (EVs) mediate cell‐to‐cell communication in development, health and disease. Heparin is a common component in human induced pluripotent stem cell (hiPSC) media but its impact on hiPSC‐EVs beyond stabilizing growth factors is ...
André Cronemberger Andrade   +13 more
doaj   +2 more sources

The anti-cancer properties of heparin and its derivatives: a review and prospect

open access: yesCell Adhesion and Migration, 2020
Heparin, including unfractionated heparin (UFH), low-molecular-weight heparin (LMWH) and heparin derivatives, are commonly used in venous thromboembolism treatment and reportedly have beneficial effects on cancer survival.
Jin-Hai Tang   +2 more
exaly   +2 more sources

Biomedical applications of engineered heparin-based materials

open access: yesBioactive Materials
Heparin is a negatively charged polysaccharide with various chain lengths and a hydrophilic backbone. Due to its fascinating chemical and physical properties, nontoxicity, biocompatibility, and biodegradability, heparin has been extensively used in ...
Haroon Khan   +2 more
exaly   +3 more sources

Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia

open access: yesThrombosis Journal, 2021
Background This is a review article on heparin-induced thrombocytopenia, an adverse effect of heparin therapy, and vaccine-induced immune thrombotic thrombocytopenia, occurring in some patients administered certain coronavirus vaccines.
Payel Datta   +3 more
doaj   +1 more source

Influence of different levels of heparin and antithrombin Ⅲ on human coagulation factor Ⅸ activity

open access: yesZhongguo shuxue zazhi, 2022
Objective To study the effect of different concentrations of heparin, ATⅢ or a mixture of heparin and antithrombin Ⅲ (ATⅢ) (1∶1)on the activity of human coagulation factor Ⅸ (FⅨ).
Changyong JIAN   +5 more
doaj   +1 more source

Quantitative Analysis of Impurities in Unfractionated Heparin of Bovine Origin

open access: yesFrontiers in Medicine, 2020
The USP heparin sodium monograph lists impurities with specifications developed for porcine derived products. Most of these impurities are of biological origin and are present in porcine intestinal mucosa, the tissue source used in the production of ...
Wesley E. Workman, Kevin L. Carrick
doaj   +1 more source

Poly-ion complex (PIC) formation of heparin and polyamines: PIC with tetrakis (3-aminopropyl) ammonium allows sustained release of heparin

open access: yesHeliyon, 2020
Physical mixtures of cationic polymers and heparin have been developed to overcome the limitations of unfractionated heparin. In this study, we found that heparin associates with natural polyamines in water, resulting in the generation of a poly-ion ...
Daichi Ito   +8 more
doaj   +1 more source

Heparin-induced thrombocytopenia occurring early after living donor liver transplantation: a case report

open access: yesEmergency and Critical Care Medicine, 2023
. Background. Thrombocytopenia commonly occurs early after liver transplantation. Heparin, usually administered as anticoagulant therapy for thrombosis, a common complication after liver transplantation, may cause heparin-induced thrombocytopenia ...
Naoya Iwasaki   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy